Literature DB >> 7907606

Adenosine triphosphate-dependent transport of doxorubicin, daunomycin, and vinblastine in human tissues by a mechanism distinct from the P-glycoprotein.

S Awasthi1, S S Singhal, S K Srivastava, P Zimniak, K K Bajpai, M Saxena, R Sharma, S A Ziller, E P Frenkel, S V Singh.   

Abstract

Previous studies have demonstrated that a human glutathione conjugate transporter, designated as dinitrophenyl-S-glutathione ATPase (DNP-SG ATPase), catalyzed ATP hydrolysis in the presence of several amphiphilic compounds other than glutathione conjugates (Singhal, S. S., R. Sharma, S. Gupta, H. Ahmad, P. Zimniak, A. Radominska, R. Lester, and Y. C. Awasthi. 1991. FEBS [Fed. Eur. Biochem. Soc.] Lett. 281:255-257). We now demonstrate that DNP-SG ATPase purified from human lung and erythrocyte membranes catalyzed the hydrolysis of ATP in the presence of doxorubicin and its metabolites. Doxorubicin-stimulated ATP hydrolysis by DNP-SG ATPase was saturable with respect to doxorubicin (Km 1.2 and 2.8 microM for the lung and erythrocyte enzymes, respectively). Antibodies against DNP-SG ATPase immunoprecipitated the ATP hydrolyzing activity stimulated by doxorubicin, its metabolites, and glutathione conjugates. Inside our vesicles prepared from erythrocyte membranes took up doxorubicin, daunomycin, and vinblastine in an ATP-dependent manner. The uptake was linear with respect to time and vesicle protein, was dependent on ATP and magnesium, was inhibited by heavy metal salts or by heating the vesicles, and was sensitive to both osmolarity and orientation of the vesicles. The transport had an activation energy of 13 kcal/mol, was saturable with respect to both doxorubicin and ATP (Km values of 1.8 microM and 1.9 mM, respectively), and was competitively inhibited by glutathione conjugates as well as by a number of amphiphiles such as daunomycin or vinblastine. Transport was diminished upon coating the vesicles with antibodies against DNP-SG ATPase. Incorporation of increasing amounts of purified DNP-SG ATPase into the vesicles resulted in a linear increase in transport of doxorubicin. These studies demonstrated for the first time that a membrane protein that catalyzed the transport of anionic amphiphilic molecules such as glutathione conjugates could also mediate the transport of weakly cationic antitumor antibiotic, doxorubicin. Notably, the Km of transport was in the range of doxorubicin concentration achievable in human serum after intravenous dosing of doxorubicin.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7907606      PMCID: PMC294005          DOI: 10.1172/JCI117102

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  32 in total

1.  A new and rapid colorimetric determination of acetylcholinesterase activity.

Authors:  G L ELLMAN; K D COURTNEY; V ANDRES; R M FEATHER-STONE
Journal:  Biochem Pharmacol       Date:  1961-07       Impact factor: 5.858

2.  A surface glycoprotein modulating drug permeability in Chinese hamster ovary cell mutants.

Authors:  R L Juliano; V Ling
Journal:  Biochim Biophys Acta       Date:  1976-11-11

3.  A novel dinitrophenylglutathione-stimulated ATPase is present in human erythrocyte membranes.

Authors:  E F LaBelle; S V Singh; H Ahmad; L Wronski; S K Srivastava; Y C Awasthi
Journal:  FEBS Lett       Date:  1988-02-08       Impact factor: 4.124

4.  Preparation of impermeable ghosts and inside-out vesicles from human erythrocyte membranes.

Authors:  T L Steck; J A Kant
Journal:  Methods Enzymol       Date:  1974       Impact factor: 1.600

5.  The transport of oxidized glutathione from human erythrocytes.

Authors:  S K Srivastava; E Beutler
Journal:  J Biol Chem       Date:  1969-01-10       Impact factor: 5.157

6.  Reversible binding of Pi by beef heart mitochondrial adenosine triphosphatase.

Authors:  H S Penefsky
Journal:  J Biol Chem       Date:  1977-05-10       Impact factor: 5.157

7.  Enzymatic conjugation of erythrocyte glutathione with 1-chloro-2,4-dinitrobenzene: the fate of glutathione conjugate in erythrocytes and the effect of glutathione depletion on hemoglobin.

Authors:  Y C Awasthi; H S Garg; D D Dao; C A Partridge; S K Srivastava
Journal:  Blood       Date:  1981-10       Impact factor: 22.113

8.  Glutathione disulfide-stimulated Mg2+-ATPase of human erythrocyte membranes.

Authors:  T Kondo; Y Kawakami; N Taniguchi; E Beutler
Journal:  Proc Natl Acad Sci U S A       Date:  1987-11       Impact factor: 11.205

9.  Studies on glutathione transport utilizing inside-out vesicles prepared from human erythrocytes.

Authors:  T Kondo; G L Dale; E Beutler
Journal:  Biochim Biophys Acta       Date:  1981-07-06

10.  Dinitrophenyl glutathione efflux from human erythrocytes is primary active ATP-dependent transport.

Authors:  E F LaBelle; S V Singh; S K Srivastava; Y C Awasthi
Journal:  Biochem J       Date:  1986-09-01       Impact factor: 3.857

View more
  34 in total

Review 1.  Role of RLIP76 in doxorubicin resistance in lung cancer.

Authors:  Rit Vatsyayan; Pankaj Chaudhary; Poorna Chandra Rao Lelsani; Preeti Singhal; Yogesh C Awasthi; Sanjay Awasthi; Sharad S Singhal
Journal:  Int J Oncol       Date:  2009-06       Impact factor: 5.650

2.  The DrrAB efflux system of Streptomyces peucetius is a multidrug transporter of broad substrate specificity.

Authors:  Wen Li; Madhu Sharma; Parjit Kaur
Journal:  J Biol Chem       Date:  2014-03-14       Impact factor: 5.157

3.  Regression of prostate cancer xenografts by RLIP76 depletion.

Authors:  Sharad S Singhal; Cherice Roth; Kathryn Leake; Jyotsana Singhal; Sushma Yadav; Sanjay Awasthi
Journal:  Biochem Pharmacol       Date:  2008-11-25       Impact factor: 5.858

4.  Overexpression of the gene encoding the multidrug resistance-associated protein results in increased ATP-dependent glutathione S-conjugate transport.

Authors:  M Müller; C Meijer; G J Zaman; P Borst; R J Scheper; N H Mulder; E G de Vries; P L Jansen
Journal:  Proc Natl Acad Sci U S A       Date:  1994-12-20       Impact factor: 11.205

5.  ATP-dependent transport of glutathione conjugate of 7beta, 8alpha-dihydroxy-9alpha,10alpha-oxy-7,8,9,10-tetrahydrobenzo[a]pyrene in murine hepatic canalicular plasma membrane vesicles.

Authors:  S K Srivastava; X Hu; H Xia; R J Bleicher; H A Zaren; J L Orchard; S Awasthi; S V Singh
Journal:  Biochem J       Date:  1998-06-15       Impact factor: 3.857

6.  Tissue distribution of the multidrug resistance protein.

Authors:  M J Flens; G J Zaman; P van der Valk; M A Izquierdo; A B Schroeijers; G L Scheffer; P van der Groep; M de Haas; C J Meijer; R J Scheper
Journal:  Am J Pathol       Date:  1996-04       Impact factor: 4.307

7.  RALBP1/RLIP76 depletion in mice suppresses tumor growth by inhibiting tumor neovascularization.

Authors:  Seunghyung Lee; Jeremy G T Wurtzel; Sharad S Singhal; Sanjay Awasthi; Lawrence E Goldfinger
Journal:  Cancer Res       Date:  2012-08-17       Impact factor: 12.701

Review 8.  RLIP76: A novel glutathione-conjugate and multi-drug transporter.

Authors:  Sharad S Singhal; Sushma Yadav; Cherice Roth; Jyotsana Singhal
Journal:  Biochem Pharmacol       Date:  2008-10-15       Impact factor: 5.858

9.  Diminished drug transport and augmented radiation sensitivity caused by loss of RLIP76.

Authors:  Sharad S Singhal; Sushma Yadav; Jyotsana Singhal; Mukesh Sahu; Archana Sehrawat; Sanjay Awasthi
Journal:  FEBS Lett       Date:  2008-09-18       Impact factor: 4.124

10.  A central role of RLIP76 in regulation of glycemic control.

Authors:  Sanjay Awasthi; Sharad S Singhal; Sushma Yadav; Jyotsana Singhal; Rit Vatsyayan; Ewa Zajac; Rafal Luchowski; Jozef Borvak; Karol Gryczynski; Yogesh C Awasthi
Journal:  Diabetes       Date:  2009-12-10       Impact factor: 9.461

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.